Activation of the sodium-potassium pump contributes to insulin-induced vasodilation in humans

Hypertension

Volumn 28, Issue 3, 1996, Pages 426-432

  Tack, Cees J J ^a   Lutterman, Jos A ^a   Vervoort, Gerald ^a   Thien, Theo ^a   Smits, Paul ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

endothelium; insulin; nitric oxide; ouabain; sodium potassium pump; vasodilation

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); INSULIN; N(G) METHYLARGININE; NEUTRAL INSULIN; NITRIC OXIDE SYNTHASE INHIBITOR; OUABAIN;

ADULT; ARTICLE; BLOOD VESSEL TONE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ENZYME ACTIVATION; FEMALE; FOREARM BLOOD FLOW; GLUCOSE TRANSPORT; HUMAN; HUMAN EXPERIMENT; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL; SKELETAL MUSCLE; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0029795468     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.28.3.426     Document Type: Article

References (37)

1. Laakso M, Edelman SV, Brechtel G, Baron AD. Decreased effect of insulin to stimulate skeletal blood flow in obese man: a novel mechanism for insulin resistance. J Clin Invest. 1990;85:1844-1852.
2. Tack CJJ, Smits P, Willemsen JJ, Lenders JWM, Thien T, Lutterman JA. Effects of insulin on vascular tone and sympathetic nervous system in NIDDM. Diabetes. 1996;45:15-22.
3. Anderson EA, Hoffmann RP, Balon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest. 1991;87:2246-2252.
4. Baron AD, Brechtel-Hook G, Johnson AD, Hardin D. Skeletal muscle blood flow: a possible link between insulin resistance and blood pressure. Hypertension. 1993;21:129-135.
5. Laakso M, Edelman SV, Brechtel G, Baron AD. Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes. 1992;41:1076-1083.
6. Baron AD, Laakso M, Brechtel G, Edelman SV. Reduced capacity and affinity of skeletal muscle for insulin-mediated glucose uptake in non-insulin-dependent diabetic subjects: effects of insulin therapy. J Clin Invest. 1991;87:1186-1194.
7. Moore RD. Effects of insulin upon ion transport. Biochim Biophys Acta. 1983;737:1-49.
8. +-ATPase: mechanisms underlying rapid and sustained changes in pump activity. Am J Physiol. 1995;269:C295-C311.
9. 2+ influx. J Nutr. 1995;125:1732S-1737S.
10. Kahn AM, Seidel CL, Allen JC, O'Neil G, Shelat H, Song T. Insulin reduces contraction and intracellular calcium concentration in vascular smooth muscle. Hypertension. 1993;22:735-742.
11. Meharg JV, McGowan-Jordan J, Charles A, Parmelee JT, Cutaia MV, Rounds S. Hydrogen peroxide stimulates sodium-potassium pump activity in cultured pulmonary arterial endothelial cells. Am J Physiol. 1993;265:L613-L621.
12. Lückhoff A, Busse R. Activators of potassium channels enhance calcium influx into endothelial cells as a consequence of potassium currents. Naunyn Schmiedebergs Arch Pharmacol. 1990;342:94-99.
13. Moncada S, Palmer RMJ. The L-arginine nitric oxide pathway in the vessel wall. In: Moncada S, Higgs, eds. Nitric Oxide From L-Arginine: A Bioregulatory System. Amsterdam, Netherlands: Elsevier; 1990:19-33.
14. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P. Nitric oxide release accounts for insulin's effects in humans. J Clin Invest. 1995;94:2511-2515.
15. Steinberg HM, Brechtel G, Johnson A, Fineberg N, Baron AD. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent: a novel action of insulin to increase nitric-oxide release. J Clin Invest. 1994;94:1172-1179.
16. + dependent ATPase molecules from intracellular stores to the plasma membrane in frog skeletal muscle. Biochem J. 1990;272:727-733.
17. Randin D, Vollenweider P, Tappy L, Jequier E, Nicod P, Scherrer U. Effects of adrenergic and cholinergic blockade on insulin-induced stimulation of calf blood flow in humans. Am J Physiol. 1994;247:R809-R816.
18. Utriainen T, Malmström R, Mäkimattila S, Yki-Järvinen H. Methodological aspects, dose-response characteristics and causes of interindividual variation in insulin stimulation of limb blood flow in normal subjects. Diabetologia. 1995;38:555-564.
19. Lundgren F, Edén E, Arfvidsson B, Lundholm K. Insulin time-dependent effects on the leg exchange of glucose and amino acids in man. Eur J Clin Invest. 1991;21:421-429.
20. Brakkee AJM, Vendrik AJH. Strain gauge plethysmography: theoretical and practical notes on a new design. J Appl Physiol. 1966;21:701-704.
21. Woolfson RG, Poston L. Effect of ouabain on endothelium-dependent relaxation of human resistance arteries. Hypertension. 1991;17:619-625.
22. Mason DT, Braunwald E. Studies on digitalis, X: effects of ouabain on forearm vascular resistance and venous tone in normal subjects and in patients with heart failure. J Clin Invest. 1964;43:532-543.
23. Pedrinelli R, Taddei S, Graziadei L, Salvetti A. Vascular responses to ouabain and norepinephrine in low and normal renin hypertension. Hypertension. 1986;8:786-792.
24. Robinson BF, Phillips RJW, Wilson PN, Chiodini PL. Effect of local infusion of ouabain on human forearm vascular resistance and on response to potassium, verapamil and sodium nitroprusside. J Hypertens. 1983;1:165-169.
25. + exchange by insulin in the human forearm. Am J Physiol. 1988;255:E953-E958.
26. Pedrinelli R, Taddei S, Salvetti A. Sympathetic vasoconstriction as a mechanism of action of ouabain in forearm arterioles of hypertensive patients. Clin Sci. 1989;77:541-545.
27. Pidgeon GB, Richards AM, Nicholls MG, Lewis LK, Yandle TG. Acute effects of intravenous ouabain in healthy volunteers. Clin Sci. 1994;86:391-397.
28. DeFronze RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;273:E214-E223.
29. Dillon RS. Importance of hematocrit in interpretation of blood sugar. Diabetes. 1965;14:672-674.
30. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14:173-194.
31. +-ATPase gene expression by insulin in vascular smooth muscle cells. Am J Hypertens. 1993;6:626-629.
32. Sampson SR, Brodie C, Alboim SV. Role of protein kinase C in insulin activation of the Na-K pump in cultured skeletal muscle. Am J Physiol. 1994;266:C751-C758.
33. Schulte K, Van Gemmeren D, Thiede H, Meyer-Sabellek W, Gotzen R, Distler A. Ouabain-induced elevation of forearm vascular resistance, calcium entry and alpha-adrenoceptor blockade and release and removal of noradrenaline. J Hypertens. 1987;5(S):S215-S218.
34. +-ATPase activity by nitric oxide: a cGMP-independent effect. Am J Physiol. 1994,266:H2146-H2151.
35. + ATPase activity in rabbit aorta by hyperglycemia: possible role of endothelium-derived nitric oxide. J Clin Invest. 1992;90:727-732.
36. --cotransporter activities in vascular endothelial cells. Am J Physiol. 1992;263:H96-H102.
37. Taddei S, Virdis A, Mattei P, Natali A, Ferrannini E, Salvetti A. Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension. Circulation. 1995;92:2911-2918.